 | • レポートコード：D0GIR-02535 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼科における一般薬物の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科における一般薬物の種類別市場規模（抗炎症薬、抗感染症薬、緑内障治療薬、抗アレルギー薬、抗VEGF剤、その他）、用途別市場規模（ドライアイ、緑内障、感染症・炎症、網膜疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Santen Pharmaceutical、Fresenius、Novartis、Mylan、Bausch Health、Johnson & Johnson、Allergan、Teva Pharmaceutical、Takeda、Chongqing Chemical & Pharmaceutical Holding (Group) Company、APOTEX、Sun Pharmaceutical、Senju Pharmaceutical、GE Medical、Taj Pharmaceuticals、Jamp Pharma ・地域別グローバル市場分析 2015年-2020年 ・眼科における一般薬物の北米市場（アメリカ、カナダ、メキシコ） ・眼科における一般薬物のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼科における一般薬物のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼科における一般薬物の南米市場（ブラジル、アルゼンチン） ・眼科における一般薬物の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗炎症薬、抗感染症薬、緑内障治療薬、抗アレルギー薬、抗VEGF剤、その他 ・用途別分析：ドライアイ、緑内障、感染症・炎症、網膜疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Common Drugs Use in Ophthalmology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Common Drugs Use in Ophthalmology sales will be xx in 2020 from Common Drugs Use in Ophthalmology million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Common Drugs Use in Ophthalmology market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Common Drugs Use in Ophthalmology industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Common Drugs Use in Ophthalmology and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Common Drugs Use in Ophthalmology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Common Drugs Use in Ophthalmology market has been segmented into:
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
By Application, Common Drugs Use in Ophthalmology has been segmented into:
Dry Eye
Glaucoma
Infection/Inflammation
Retinal Disorders
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Common Drugs Use in Ophthalmology market presented in the report. This section sheds light on the sales growth of different regional and country-level Common Drugs Use in Ophthalmology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Common Drugs Use in Ophthalmology market.
The report offers in-depth assessment of the growth and other aspects of the Common Drugs Use in Ophthalmology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Common Drugs Use in Ophthalmology Market Share Analysis
Common Drugs Use in Ophthalmology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Common Drugs Use in Ophthalmology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Common Drugs Use in Ophthalmology sales, revenue and market share for each player covered in this report.
The major players covered in Common Drugs Use in Ophthalmology are:
Pfizer
Santen Pharmaceutical
Fresenius
Novartis
Mylan
Bausch Health
Johnson & Johnson
Allergan
Teva Pharmaceutical
Takeda
Chongqing Chemical & Pharmaceutical Holding (Group) Company
APOTEX
Sun Pharmaceutical
Senju Pharmaceutical
GE Medical
Taj Pharmaceuticals
Jamp Pharma
Among other players domestic and global, Common Drugs Use in Ophthalmology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Common Drugs Use in Ophthalmology Market Overview
1.1 Product Overview and Scope of Common Drugs Use in Ophthalmology
1.2 Classification of Common Drugs Use in Ophthalmology by Type
1.2.1 Global Common Drugs Use in Ophthalmology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Common Drugs Use in Ophthalmology Revenue Market Share by Type in 2019
1.2.3 Anti-inflammatory Drugs
1.2.4 Anti-infective Drugs
1.2.5 Anti-glaucoma Drugs
1.2.6 Anti-allergy Drugs
1.2.7 Anti-VEGF Agents
1.2.8 Others
1.3 Global Common Drugs Use in Ophthalmology Market by Application
1.3.1 Overview: Global Common Drugs Use in Ophthalmology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dry Eye
1.3.3 Glaucoma
1.3.4 Infection/Inflammation
1.3.5 Retinal Disorders
1.3.6 Others
1.4 Global Common Drugs Use in Ophthalmology Market by Regions
1.4.1 Global Common Drugs Use in Ophthalmology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Common Drugs Use in Ophthalmology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Common Drugs Use in Ophthalmology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Common Drugs Use in Ophthalmology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Common Drugs Use in Ophthalmology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Common Drugs Use in Ophthalmology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Common Drugs Use in Ophthalmology Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Common Drugs Use in Ophthalmology Industry Impact
1.5.1 COVID-19 Potential Implications for the Common Drugs Use in Ophthalmology
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Common Drugs Use in Ophthalmology
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Santen Pharmaceutical
2.2.1 Santen Pharmaceutical Details
2.2.2 Santen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Santen Pharmaceutical SWOT Analysis
2.2.4 Santen Pharmaceutical Product and Services
2.2.5 Santen Pharmaceutical Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fresenius
2.3.1 Fresenius Details
2.3.2 Fresenius Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fresenius SWOT Analysis
2.3.4 Fresenius Product and Services
2.3.5 Fresenius Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bausch Health Product and Services
2.6.4 Bausch Health Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson Product and Services
2.7.4 Johnson & Johnson Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan Product and Services
2.8.4 Allergan Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Product and Services
2.9.4 Teva Pharmaceutical Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda Product and Services
2.10.4 Takeda Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Chongqing Chemical & Pharmaceutical Holding (Group) Company
2.11.1 Chongqing Chemical & Pharmaceutical Holding (Group) Company Details
2.11.2 Chongqing Chemical & Pharmaceutical Holding (Group) Company Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Chongqing Chemical & Pharmaceutical Holding (Group) Company Product and Services
2.11.4 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.12 APOTEX
2.12.1 APOTEX Details
2.12.2 APOTEX Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 APOTEX Product and Services
2.12.4 APOTEX Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sun Pharmaceutical
2.13.1 Sun Pharmaceutical Details
2.13.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sun Pharmaceutical Product and Services
2.13.4 Sun Pharmaceutical Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.14 Senju Pharmaceutical
2.14.1 Senju Pharmaceutical Details
2.14.2 Senju Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Senju Pharmaceutical Product and Services
2.14.4 Senju Pharmaceutical Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.15 GE Medical
2.15.1 GE Medical Details
2.15.2 GE Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 GE Medical Product and Services
2.15.4 GE Medical Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.16 Taj Pharmaceuticals
2.16.1 Taj Pharmaceuticals Details
2.16.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Taj Pharmaceuticals Product and Services
2.16.4 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
2.17 Jamp Pharma
2.17.1 Jamp Pharma Details
2.17.2 Jamp Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Jamp Pharma Product and Services
2.17.4 Jamp Pharma Common Drugs Use in Ophthalmology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Common Drugs Use in Ophthalmology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Common Drugs Use in Ophthalmology Players Market Share
3.2.2 Top 10 Common Drugs Use in Ophthalmology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Common Drugs Use in Ophthalmology Revenue and Market Share by Regions
4.2 North America Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
4.3 Europe Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
4.5 South America Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
5 North America Common Drugs Use in Ophthalmology Revenue by Countries
5.1 North America Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
5.2 USA Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
5.3 Canada Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
5.4 Mexico Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
6 Europe Common Drugs Use in Ophthalmology Revenue by Countries
6.1 Europe Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
6.2 Germany Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
6.3 UK Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
6.4 France Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
6.5 Russia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
6.6 Italy Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Common Drugs Use in Ophthalmology Revenue by Countries
7.1 Asia-Pacific Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
7.2 China Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
7.3 Japan Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
7.4 Korea Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
7.5 India Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
8 South America Common Drugs Use in Ophthalmology Revenue by Countries
8.1 South America Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
8.2 Brazil Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
8.3 Argentina Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Common Drugs Use in Ophthalmology by Countries
9.1 Middle East & Africa Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
9.3 UAE Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
9.4 Egypt Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
9.5 South Africa Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Common Drugs Use in Ophthalmology Revenue and Market Share by Type (2015-2020)
10.2 Global Common Drugs Use in Ophthalmology Market Forecast by Type (2019-2024)
10.3 Anti-inflammatory Drugs Revenue Growth Rate (2015-2025)
10.4 Anti-infective Drugs Revenue Growth Rate (2015-2025)
10.5 Anti-glaucoma Drugs Revenue Growth Rate (2015-2025)
10.6 Anti-allergy Drugs Revenue Growth Rate (2015-2025)
10.7 Anti-VEGF Agents Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Common Drugs Use in Ophthalmology Market Segment by Application
11.1 Global Common Drugs Use in Ophthalmology Revenue Market Share by Application (2015-2020)
11.2 Common Drugs Use in Ophthalmology Market Forecast by Application (2019-2024)
11.3 Dry Eye Revenue Growth (2015-2020)
11.4 Glaucoma Revenue Growth (2015-2020)
11.5 Infection/Inflammation Revenue Growth (2015-2020)
11.6 Retinal Disorders Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Common Drugs Use in Ophthalmology Market Size Forecast (2021-2025)
12.1 Global Common Drugs Use in Ophthalmology Market Size Forecast (2021-2025)
12.2 Global Common Drugs Use in Ophthalmology Market Forecast by Regions (2021-2025)
12.3 North America Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
12.4 Europe Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
12.6 South America Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Common Drugs Use in Ophthalmology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Common Drugs Use in Ophthalmology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Common Drugs Use in Ophthalmology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Common Drugs Use in Ophthalmology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Common Drugs Use in Ophthalmology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Pfizer Corporate Information, Location and Competitors
Table 7. Pfizer Common Drugs Use in Ophthalmology Major Business
Table 8. Pfizer Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 9. Pfizer SWOT Analysis
Table 10. Pfizer Common Drugs Use in Ophthalmology Product and Solutions
Table 11. Pfizer Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Santen Pharmaceutical Corporate Information, Location and Competitors
Table 13. Santen Pharmaceutical Common Drugs Use in Ophthalmology Major Business
Table 14. Santen Pharmaceutical Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2018-2019)
Table 15. Santen Pharmaceutical SWOT Analysis
Table 16. Santen Pharmaceutical Common Drugs Use in Ophthalmology Product and Solutions
Table 17. Santen Pharmaceutical Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Fresenius Corporate Information, Location and Competitors
Table 19. Fresenius Common Drugs Use in Ophthalmology Major Business
Table 20. Fresenius Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 21. Fresenius SWOT Analysis
Table 22. Fresenius Common Drugs Use in Ophthalmology Product and Solutions
Table 23. Fresenius Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Novartis Corporate Information, Location and Competitors
Table 25. Novartis Common Drugs Use in Ophthalmology Major Business
Table 26. Novartis Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 27. Novartis SWOT Analysis
Table 28. Novartis Common Drugs Use in Ophthalmology Product and Solutions
Table 29. Novartis Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Mylan Corporate Information, Location and Competitors
Table 31. Mylan Common Drugs Use in Ophthalmology Major Business
Table 32. Mylan Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 33. Mylan SWOT Analysis
Table 34. Mylan Common Drugs Use in Ophthalmology Product and Solutions
Table 35. Mylan Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bausch Health Corporate Information, Location and Competitors
Table 37. Bausch Health Common Drugs Use in Ophthalmology Major Business
Table 38. Bausch Health Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 39. Bausch Health SWOT Analysis
Table 40. Bausch Health Common Drugs Use in Ophthalmology Product and Solutions
Table 41. Bausch Health Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Johnson & Johnson Corporate Information, Location and Competitors
Table 43. Johnson & Johnson Common Drugs Use in Ophthalmology Major Business
Table 44. Johnson & Johnson Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 45. Johnson & Johnson SWOT Analysis
Table 46. Johnson & Johnson Common Drugs Use in Ophthalmology Product and Solutions
Table 47. Johnson & Johnson Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Allergan Corporate Information, Location and Competitors
Table 49. Allergan Common Drugs Use in Ophthalmology Major Business
Table 50. Allergan Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 51. Allergan SWOT Analysis
Table 52. Allergan Common Drugs Use in Ophthalmology Product and Solutions
Table 53. Allergan Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 55. Teva Pharmaceutical Common Drugs Use in Ophthalmology Major Business
Table 56. Teva Pharmaceutical Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 57. Teva Pharmaceutical SWOT Analysis
Table 58. Teva Pharmaceutical Common Drugs Use in Ophthalmology Product and Solutions
Table 59. Teva Pharmaceutical Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Takeda Corporate Information, Location and Competitors
Table 61. Takeda Common Drugs Use in Ophthalmology Major Business
Table 62. Takeda Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 63. Takeda SWOT Analysis
Table 64. Takeda Common Drugs Use in Ophthalmology Product and Solutions
Table 65. Takeda Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Chongqing Chemical & Pharmaceutical Holding (Group) Company Corporate Information, Location and Competitors
Table 67. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Major Business
Table 68. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 69. Chongqing Chemical & Pharmaceutical Holding (Group) Company SWOT Analysis
Table 70. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Product and Solutions
Table 71. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. APOTEX Corporate Information, Location and Competitors
Table 73. APOTEX Common Drugs Use in Ophthalmology Major Business
Table 74. APOTEX Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 75. APOTEX SWOT Analysis
Table 76. APOTEX Common Drugs Use in Ophthalmology Product and Solutions
Table 77. APOTEX Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 79. Sun Pharmaceutical Common Drugs Use in Ophthalmology Major Business
Table 80. Sun Pharmaceutical Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 81. Sun Pharmaceutical SWOT Analysis
Table 82. Sun Pharmaceutical Common Drugs Use in Ophthalmology Product and Solutions
Table 83. Sun Pharmaceutical Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Senju Pharmaceutical Corporate Information, Location and Competitors
Table 85. Senju Pharmaceutical Common Drugs Use in Ophthalmology Major Business
Table 86. Senju Pharmaceutical Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 87. Senju Pharmaceutical SWOT Analysis
Table 88. Senju Pharmaceutical Common Drugs Use in Ophthalmology Product and Solutions
Table 89. Senju Pharmaceutical Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. GE Medical Corporate Information, Location and Competitors
Table 91. GE Medical Common Drugs Use in Ophthalmology Major Business
Table 92. GE Medical Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 93. GE Medical SWOT Analysis
Table 94. GE Medical Common Drugs Use in Ophthalmology Product and Solutions
Table 95. GE Medical Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Taj Pharmaceuticals Corporate Information, Location and Competitors
Table 97. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Major Business
Table 98. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 99. Taj Pharmaceuticals SWOT Analysis
Table 100. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Product and Solutions
Table 101. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Jamp Pharma Corporate Information, Location and Competitors
Table 103. Jamp Pharma Common Drugs Use in Ophthalmology Major Business
Table 104. Jamp Pharma Common Drugs Use in Ophthalmology Total Revenue (USD Million) (2017-2018)
Table 105. Jamp Pharma SWOT Analysis
Table 106. Jamp Pharma Common Drugs Use in Ophthalmology Product and Solutions
Table 107. Jamp Pharma Common Drugs Use in Ophthalmology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Common Drugs Use in Ophthalmology Revenue (Million USD) by Players (2015-2020)
Table 109. Global Common Drugs Use in Ophthalmology Revenue Share by Players (2015-2020)
Table 110. Global Common Drugs Use in Ophthalmology Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Common Drugs Use in Ophthalmology Revenue Market Share by Regions (2015-2020)
Table 112. North America Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
Table 113. North America Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 114. Europe Common Drugs Use in Ophthalmology Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Common Drugs Use in Ophthalmology Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Common Drugs Use in Ophthalmology Revenue by Countries (2015-2020)
Table 117. South America Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Common Drugs Use in Ophthalmology Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Table 120. Global Common Drugs Use in Ophthalmology Revenue (Million USD) by Type (2015-2020)
Table 121. Global Common Drugs Use in Ophthalmology Revenue Share by Type (2015-2020)
Table 122. Global Common Drugs Use in Ophthalmology Revenue Forecast by Type (2021-2025)
Table 123. Global Common Drugs Use in Ophthalmology Revenue by Application (2015-2020)
Table 124. Global Common Drugs Use in Ophthalmology Revenue Share by Application (2015-2020)
Table 125. Global Common Drugs Use in Ophthalmology Revenue Forecast by Application (2021-2025)
Table 126. Global Common Drugs Use in Ophthalmology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Common Drugs Use in Ophthalmology Picture
Figure 2. Global Common Drugs Use in Ophthalmology Revenue Market Share by Type in 2019
Figure 3. Anti-inflammatory Drugs Picture
Figure 4. Anti-infective Drugs Picture
Figure 5. Anti-glaucoma Drugs Picture
Figure 6. Anti-allergy Drugs Picture
Figure 7. Anti-VEGF Agents Picture
Figure 8. Others Picture
Figure 9. Common Drugs Use in Ophthalmology Revenue Market Share by Application in 2019
Figure 10. Dry Eye Picture
Figure 11. Glaucoma Picture
Figure 12. Infection/Inflammation Picture
Figure 13. Retinal Disorders Picture
Figure 14. Others Picture
Figure 15. Global Common Drugs Use in Ophthalmology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Common Drugs Use in Ophthalmology Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Common Drugs Use in Ophthalmology Revenue Market Share in 2019
Figure 24. Global Top 10 Players Common Drugs Use in Ophthalmology Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Common Drugs Use in Ophthalmology Revenue Market Share by Regions (2015-2020)
Figure 28. Global Common Drugs Use in Ophthalmology Revenue Market Share by Regions in 2018
Figure 29. North America Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 30. Europe Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 32. South America Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 34. North America Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 35. North America Common Drugs Use in Ophthalmology Revenue Market Share by Countries in 2019
Figure 36. USA Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 37. Canada Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 39. Europe Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Common Drugs Use in Ophthalmology Revenue Market Share by Countries in 2019
Figure 41. Germany Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 42. UK Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 43. France Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 44. Russia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 45. Italy Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Common Drugs Use in Ophthalmology Revenue Market Share by Countries in 2019
Figure 48. China Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 49. Japan Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 50. Korea Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 51. India Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 53. South America Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 54. South America Common Drugs Use in Ophthalmology Revenue Market Share by Countries in 2019
Figure 55. Brazil Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Common Drugs Use in Ophthalmology Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Common Drugs Use in Ophthalmology Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 60. UAE Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Common Drugs Use in Ophthalmology Revenue and Growth Rate (2015-2020)
Figure 63. Global Common Drugs Use in Ophthalmology Revenue Share by Type (2015-2020)
Figure 64. Global Common Drugs Use in Ophthalmology Revenue Share by Type in 2019
Figure 65. Global Common Drugs Use in Ophthalmology Market Share Forecast by Type (2021-2025)
Figure 66. Global Anti-inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Anti-infective Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-glaucoma Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Anti-allergy Drugs Revenue Growth Rate (2015-2020)
Figure 70. Global Anti-VEGF Agents Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Common Drugs Use in Ophthalmology Revenue Share by Application (2015-2020)
Figure 73. Global Common Drugs Use in Ophthalmology Revenue Share by Application in 2019
Figure 74. Global Common Drugs Use in Ophthalmology Market Share Forecast by Application (2021-2025)
Figure 75. Global Dry Eye Revenue Growth Rate (2015-2020)
Figure 76. Global Glaucoma Revenue Growth Rate (2015-2020)
Figure 77. Global Infection/Inflammation Revenue Growth Rate (2015-2020)
Figure 78. Global Retinal Disorders Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Common Drugs Use in Ophthalmology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Common Drugs Use in Ophthalmology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Common Drugs Use in Ophthalmology Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
Figure 84. Europe Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
Figure 86. South America Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Common Drugs Use in Ophthalmology Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
非ステロイド性抗炎症薬（NSAID）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…- 抗肥満薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-obesity Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-obesity Drugs market …
- アンチエイジング薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-aging Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-aging Drugs market repo…
- 泌尿生殖器薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…
- バーター症候群薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…